13G Filing: Healthcare Royalty Partners III, L.p. and Coherus Biosciences, Inc. (CHRS)

Page 13 of 14

Page 13 of 14 SEC Filing


CUSIP No. 19249H103

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

Date: March 9, 2016

HEALTHCARE ROYALTY PARTNERS III, L.P.
By: HealthCare Royalty GP III, LLC, its general partner
By:

/s/ Todd C. Davis

Todd C. Davis
Managing Partner
HEALTHCARE ROYALTY GP III, LLC, as general partner of HealthCare Royalty Partners III, L.P.
By:

/s/ Todd C. Davis

Todd C. Davis
Managing Partner
HEALTHCARE ROYALTY MANAGEMENT, LLC, as Investment Manager
By:

/s/ Todd C. Davis

Todd C. Davis
Managing Partner

/s/ Todd C. Davis

Name: Todd C. Davis
Title: Managing Partner, HealthCare Royalty Management, LLC

/s/ Clarke B. Futch

Name: Clarke B. Futch
Title: Managing Partner, HealthCare Royalty Management, LLC

/s/ Christopher A. White

Name: Christopher A. White
Title: Chief Operating Officer, HealthCare Royalty Management, LLC

/s/ Michael G. Carter

Name: Michael G. Carter
Title: Investment Committee Member, HealthCare Royalty Management, LLC

Page 13 of 16

Follow Coherus Biosciences Inc. (NASDAQ:CHRS)

Page 13 of 14